Cargando…
A theranostic PSMA ligand for PET imaging and retargeting of T cells expressing the universal chimeric antigen receptor UniCAR
Chimeric antigen receptor (CAR) T cells have shown impressive therapeutic potential. Due to the lack of direct control mechanisms, therapy-related adverse reactions including cytokine release- and tumor lysis syndrome can even become life-threatening. In case of target antigen expression on non-mali...
Autores principales: | Arndt, Claudia, Feldmann, Anja, Koristka, Stefanie, Schäfer, Martin, Bergmann, Ralf, Mitwasi, Nicola, Berndt, Nicole, Bachmann, Dominik, Kegler, Alexandra, Schmitz, Marc, Puentes-Cala, Edinson, Soto, Javier Andrés, Ehninger, Gerhard, Pietzsch, Jens, Liolios, Christos, Wunderlich, Gerd, Kotzerke, Jörg, Kopka, Klaus, Bachmann, Michael |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6791425/ https://www.ncbi.nlm.nih.gov/pubmed/31646084 http://dx.doi.org/10.1080/2162402X.2019.1659095 |
Ejemplares similares
-
An oligo-His-tag of a targeting module does not influence its biodistribution and the retargeting capabilities of UniCAR T cells
por: Jureczek, Justyna, et al.
Publicado: (2019) -
Development of novel target modules for retargeting of UniCAR T cells to GD2 positive tumor cells
por: Mitwasi, Nicola, et al.
Publicado: (2017) -
Retargeting of T lymphocytes to PSCA- or PSMA positive prostate cancer cells using the novel modular chimeric antigen receptor platform technology “UniCAR”
por: Feldmann, Anja, et al.
Publicado: (2017) -
Retargeting of UniCAR T cells with an in vivo synthesized target module directed against CD19 positive tumor cells
por: Bachmann, Dominik, et al.
Publicado: (2017) -
T cells engrafted with a UniCAR 28/z outperform UniCAR BB/z-transduced T cells in the face of regulatory T cell-mediated immunosuppression
por: Kegler, Alexandra, et al.
Publicado: (2019)